BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS


 Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb Company
Employees:
Symbol: BMY
 





Collaborations

Gilead Sciences, Inc. 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys, Inc.  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co., Inc.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead Sciences, Inc. (Durham, NC) 

Phyton Biotech, Inc.  - Cancer

Gilead Sciences, Inc. (Seattle, WA) 





 Company News
Bristol-Myers Squibb Company (BMY) Announces Intention to Voluntarily Delist Preferred Stock 5/17/2013 9:50:13 AM    More...
Bristol-Myers Squibb Company (BMY) to Hold Investor Teleconference to Discuss American Society of Clinical Oncology Highlights 5/16/2013 8:53:31 AM    More...
Bristol-Myers Squibb Company (BMY) to Present at UBS Global Health Care Conference 5/15/2013 7:43:22 AM    More...
Bristol-Myers Squibb Company (BMY) to Present at Bank of America (BAC) Merrill Lynch Health Care Conference 5/8/2013 9:04:31 AM    More...
Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) Announce Publication of ARISTOTLE Subanalysis in Circulation 5/7/2013 11:16:09 AM    More...
AstraZeneca PLC (AZN) and Bristol-Myers Squibb Company (BMY) Receive Award from Major Medical Association 5/7/2013 11:06:28 AM    More...
Bristol-Myers Squibb Company (BMY), AstraZeneca PLC (AZN) Release: Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients With Lipodystrophy During a 12-Month Period 5/6/2013 10:06:55 AM    More...
Bristol-Myers Squibb Company (BMY) Says FDA OKs Supplemental NDA for SUSTIVA 5/3/2013 7:24:14 AM    More...
Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY) to Jointly Study Potential Hepatitis C Virus Drug 4/22/2013 7:33:04 AM    More...
Quintiles, Inc. (QTRN) Selected as Preferred Central Laboratory Provider by Bristol-Myers Squibb Company (BMY) 4/11/2013 12:24:18 PM    More...
12345678910...